A Landscape of Driver Mutations in Melanoma
暂无分享,去创建一个
A. Sivachenko | K. Cibulskis | S. Gabriel | E. Lander | L. Chin | G. Getz | M. Meyerson | D. Schadendorf | R. Onofrio | K. Ardlie | W. Winckler | M. Lawrence | Nicolas Stransky | L. Garraway | E. Nickerson | G. Kryukov | A. Ramos | D. Auclair | G. Saksena | Douglas Voet | M. Noble | Danielle Dicara | M. Imieliński | Eran Hodis | S. Wagner | J. Wargo | M. Davies | J. Gershenwald | D. Morton | S. Arold | J. Ladbury | K. Stemke-Hale | D. Hoon | N. Wagle | Guo Chen | I. Watson | J. Theurillat | Liren Li | C. Place | K. Chong | M. Davies | K. Stemke‐Hale | D. Dicara | N. Stransky | Jean-Philippe P. Theurillat
[1] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[2] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[3] K. Flaherty,et al. From genes to drugs: targeted strategies for melanoma , 2012, Nature Reviews Cancer.
[4] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[5] Eric S. Lander,et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.
[6] J. Silberg,et al. A transposase strategy for creating libraries of circularly permuted proteins , 2012, Nucleic acids research.
[7] C. V. Jongeneel,et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.
[8] R. Gibbs,et al. Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing , 2011, Nature Genetics.
[9] The UniProt Consortium,et al. Reorganizing the protein space at the Universal Protein Resource (UniProt) , 2011, Nucleic Acids Res..
[10] Kristian Cibulskis,et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data , 2011, Bioinform..
[11] Michael A Choti,et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.
[12] J. Shendure,et al. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data , 2011, Nature Reviews Genetics.
[13] Raul Rabadan,et al. Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.
[14] Gerald C. Chu,et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.
[15] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[16] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[17] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[18] Andrea Bugarcic,et al. Phox homology band 4.1/ezrin/radixin/moesin-like proteins function as molecular scaffolds that interact with cargo receptors and Ras GTPases , 2011, Proceedings of the National Academy of Sciences.
[19] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[20] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[21] Sean Davis,et al. Interferon-γ links ultraviolet radiation to melanomagenesis in mice. , 2011, Nature.
[22] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[23] F. Barr,et al. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2 , 2010, The Journal of cell biology.
[24] R. Medema,et al. Shared and separate functions of polo-like kinases and aurora kinases in cancer , 2010, Nature Reviews Cancer.
[25] J. Cherfils,et al. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? , 2010, Nature Reviews Cancer.
[26] Jonathan W. Pillow,et al. POSTER PRESENTATION Open Access , 2013 .
[27] D. Fisher,et al. How Sunlight Causes Melanoma , 2010, Current oncology reports.
[28] L. Chin,et al. Integrative Genome Comparison of Primary and Metastatic Melanomas , 2010, PloS one.
[29] Rodrigo Lopez,et al. A new bioinformatics analysis tools framework at EMBL–EBI , 2010, Nucleic Acids Res..
[30] A. Sparks,et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.
[31] J. Maguire,et al. Integrative analysis of the melanoma transcriptome. , 2010, Genome research.
[32] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[33] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[34] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[35] Victor G Prieto,et al. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma , 2009, Clinical Cancer Research.
[36] R. Karlsson,et al. Rho GTPase function in tumorigenesis. , 2009, Biochimica et biophysica acta.
[37] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[38] J. Maguire,et al. Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.
[39] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[40] G. Mills,et al. A novel AKT3 mutation in melanoma tumours and cell lines , 2008, British Journal of Cancer.
[41] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[42] T. Golub,et al. Modeling genomic diversity and tumor dependency in malignant melanoma. , 2008, Cancer research.
[43] Takashi Ohama,et al. Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. , 2008, Biochemistry.
[44] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[45] Guy Cavet,et al. Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.
[46] David L. Brautigan,et al. Protein Phosphatase PP6 N Terminal Domain Restricts G1 to S Phase Progression in Human Cancer Cells , 2007, Cell cycle.
[47] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[48] D. Schadendorf,et al. B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis , 2007, PloS one.
[49] Wenqing Xu,et al. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme , 2007, Nature.
[50] L. Chin,et al. Malignant melanoma: genetics and therapeutics in the genomic era. , 2006, Genes & development.
[51] M. Stratton,et al. Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer , 2006, Genetics.
[52] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[53] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[54] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[55] T. Mak,et al. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis. , 2005, Cancer research.
[56] M. Garnett,et al. Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF. , 2005, Cancer research.
[57] Alan Hall,et al. Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.
[58] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[59] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[60] D. Birnbaum,et al. Aurora B -TACC1 protein complex in cytokinesis , 2004, Oncogene.
[61] B. Séraphin,et al. TACC1–chTOG–Aurora A protein complex in breast cancer , 2003, Oncogene.
[62] M. Barbacid,et al. RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.
[63] K. Hahn,et al. Localized Rac activation dynamics visualized in living cells. , 2000, Science.
[64] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[65] M. Karin,et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.